Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 3:18 AM
Ignite Modification Date:
2025-12-25 @ 3:18 AM
NCT ID:
NCT04794205
Eligibility Criteria:
Inclusion Criteria:
* Males and females of all races and ethnicities.
* 18/50 yrs old.
* Medically healthy (as determined by medical history and treatment).
* No current substance abuse disorder
* Adequate comprehension of English in order to complete study materials.
* Able and willing to provide written informed consent, and willing to commit to the study protocol.
Exclusion Criteria:
* Estimated premorbid intellectual disability \<80 (WRAT-4)
* Neurological or medical disorder that may affect brain function.
* Comorbid DSM-V diagnosis of alcohol or substance abuse in prior 1 month or substance dependence in prior 3 months
* Vulnerable populations (e.g. pregnant, nursing, incarcerated); unwillingness to use reliable means of contraception.
* High risk for suicide defined as \> 1 attempt in past 12 months that required medical attention, any attempt in the past 3 months or current suicidal ideation with plan and intent such that outpatient care is precluded.
* Current homicidal ideation with plan and intent such that outpatient care is precluded.
* Positive result on urine toxicology test for any substance, including CBD
* Any current acute or chronic pain condition
* Current use of any pain prescribed ROTC medications including opioids, NSAIDs, acetaminophen etc.
* Initial detection of abnormal liver function tests or CBC (see below)
* Initial detection of significant EKG abnormality
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
50 Years
Study:
NCT04794205
Study Brief:
Protocol Section:
NCT04794205